【Japan Pharmaceutical Industry】Share Buyback and Reward System Introduction ｜ August 2026

Disposal Details and Objectives

Japan Pharmaceutical Industry will dispose of 22,379 shares of common stock at 4,048 yen per share on August 19, 2026. The purpose of the disposal is to promote the ongoing enhancement of corporate value and the sharing of value with shareholders by introducing a remuneration system. A new system will be implemented to allocate restricted stock to directors as a form of compensation, reinforcing incentives while minimizing share dilution. The disposal will be conducted based on a resolution of the Board of Directors, with the disposal price aligned with the market stock price.

Future Outlook and Impact on Shareholders

With this system, target directors will hold shares with transfer restrictions for a certain period, committing to the improvement of corporate value. The disposed shares aim to limit shareholder dilution while enhancing director incentives. Moving forward, the company will appropriately manage the system operations and stock management to ensure sustainable growth and maximize shareholder value.